Dr Reddy's Laboratories Ltd said on Monday an independent board found Russia's Sputnik V COVID-19 vaccine to be safe in its mid-stage trial in India, and recommended progressing to late-stage trials.
The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials, Dr.Reddy's said in a regulatory filing.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
COMMENTS
Advertisement
Dominica To Award Its Highest National Honour To PM Modi Tuberculosis Replaces Covid As Top Infectious Disease Killer, Says WHO What Is A Tripledemic? Lookout For These Three Viruses That Cause Severe Respiratory Health Issues "Go Falcon. Go GSAT-20": SpaceX Successfully Launches Indian Satellite Why Donald Trump's Cabinet Choices Are Giving Pakistan Sleepless Nights Dhaka, Islamabad Inch Closer With Historic Sea Link. How It Impacts India China's Xi Jinping Urges G20 Leaders To Help "Cool" Ukraine Crisis Timeline: Key Events Leading Up To US Presidential Inauguration Kim Jong Un Meets Russia's Minister In Pyongyang As Ukraine War Deepens Ties Track Latest News Live on NDTV.com and get news updates from India and around the world.